AARTI DRUGS LTD Share Price

BSE

Company Profile


Aarti Drugs Limited was established in 1984 and forms part of the $900 Million Aarti Group of Industries, with a robust R&D division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and also produces formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited. The products under APIs include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, etc., whereas specialty chemicals include benzene sulphonyl chloride, methyl nicotinate, etc. With the government initiative to encourage private health insurance schemes, consumer spending on medicines is expected to increase, which will spur growth in the generic sector in the domestic market.

Return Calculator

This tools helps you project your potential returns on investments for the given stock, for a specified amount over a pre-defined period of time.

Invested amount

Investment period

1 year
2 year
5 year
=
up down
Returns
CAGR
%